Working… Menu

Hydroxychloroquine for the Treatment of Mild COVID-19 Disease (COMIHY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04340544
Recruitment Status : Terminated (It appeared to be impossible for the study centres to recruit the targeted number of patients, due to reduced incidence and reduced acceptance to IMP)
First Posted : April 9, 2020
Last Update Posted : November 2, 2020
Robert Bosch Medical Center
Universitätsklinikum Hamburg-Eppendorf
Bernhard Nocht Institute for Tropical Medicine
Information provided by (Responsible Party):
University Hospital Tuebingen

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : October 12, 2020
Actual Study Completion Date : October 12, 2020